Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]).

Breast cancer research : BCR·2025
Same author

Constitutively elevated levels of SOCS1 suppress innate responses in DF-1 immortalised chicken fibroblast cells.

Scientific reports·2017
Same author

Human IFIT1 Inhibits mRNA Translation of Rubulaviruses but Not Other Members of the Paramyxoviridae Family.

Journal of virology·2016
Same author

Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction.

Journal of virology·2013
Same author

ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of parainfluenza virus type 5 transcription and protein synthesis.

The Journal of general virology·2012
Same author

Activation of the beta interferon promoter by paramyxoviruses in the absence of virus protein synthesis.

The Journal of general virology·2011

関連する実験動画

Updated: May 11, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

ヒトベータインターフェロン遺伝子増強剤は,負のコントロール下にある.

S Goodbourn, H Burstein, T Maniatis

    Cell
    |May 23, 1986
    PubMed
    まとめ

    人間のベータインターフェロン遺伝子発現は,その強化体内の負の調節配列によって制御されます. 構成的な転写要素の減圧は,誘導時に遺伝子の活性化の鍵です.

    科学分野:

    • 分子生物学は分子生物学である.
    • 遺伝子規制 遺伝子規制
    • 免疫学 免疫学とは

    背景:

    • 人間のベータインターフェロン遺伝子は,先天的な免疫応答において重要な役割を果たします.
    • その発現は,誘導可能な強化要素によって厳格に調節されます.
    • 制御メカニズムを理解することは,免疫反応とウイルス感染症の制御に不可欠です.

    研究 の 目的:

    • 人間のベータインターフェロン遺伝子増強剤の規制メカニズムを調査する.
    • ネガティブコントロールとインダクションに起因する特定の配列を特定する.
    • ベータインターフェロン遺伝子調節における構成的転写要素の役割を明らかにする.

    主な方法:

    • ヒューマンベータインターフェロン増強剤要素の削除分析.
    • ベータインターフェロンのmRNA値の定量化.
    • 転写活動と誘導比の評価.

    主要な成果:

    • 強化剤から3'配列を削除すると,基礎ベータインターフェロンmRNA濃度が大幅に上昇します.
    • ベータインターフェロン発現の誘導比は,3'削除で減少した.
    • 増強剤の残りの5'領域は,ウイルス増強剤に似た強力な構成的転写活性を示した.

    さらに関連する動画

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
    09:35

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

    Published on: February 1, 2017

    Inducible and Reversible Dominant-negative (DN) Protein Inhibition
    08:35

    Inducible and Reversible Dominant-negative (DN) Protein Inhibition

    Published on: January 7, 2019

    関連する実験動画

    Last Updated: May 11, 2026

    Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
    08:32

    Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

    Published on: March 2, 2014

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
    09:35

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

    Published on: February 1, 2017

    Inducible and Reversible Dominant-negative (DN) Protein Inhibition
    08:35

    Inducible and Reversible Dominant-negative (DN) Protein Inhibition

    Published on: January 7, 2019

    結論:

    • ベータインターフェロン増強剤は,構成的転写要素と負の調節配列で構成されています.
    • この負の配列は,誘導前に増強剤の活性化を阻害し,脱圧メカニズムを示唆する.
    • 構成的な転写要素の減圧は,ヒトβインターフェロン遺伝子発現を制御する重要なメカニズムである.